Yuekang Pharmaceutical (688658.SH) injectable cefmetazole sodium passed generic drug consistency evaluation

Zhitongcaijing · 10/18 07:41

Zhitong Finance App News, Yuekang Pharmaceutical (688658.SH) announced that the company received the “Drug Supplement Application Approval Notice” for injectable cefumezole sodium (specification: 0.5g) approved and issued by the State Drug Administration. The drug passed the consistent evaluation of the quality and efficacy of generic drugs.

According to reports, injectable cefmetazole sodium is mainly suitable for treating infections caused by Staphylococcus aureus, Escherichia coli, pneumococcus, Proteus, Morse Morganella, Providence, Streptococcus spp., Bacillus spp., and Prevoracter spp. (other than Prévolobacter bacillus), including sepsis, acute bronchitis, pneumonia, lung abscesses, empyema, and chronic respiratory diseases secondary infections, cystitis, pyelitis, cholecystitis, cholangitis, bartholinitis, intrauterine infection, adnexitis, parauterine tissue inflammation, cellulitis around the jaw inflammation, jaw inflammation.